TSSC4: A Potential Drug Target and Biomarker for Advanced Cancer

Target Name: TSSC4

NCBI ID: G10078

TSSC4

Other Name(s): Tumor-suppressing subchromosomal transferable fragment candidate gene 4 protein | Tumor suppressing subtransferable candidate 4, transcript variant 3 | tumor-suppressing subchromosomal transferable fragment candidate gene 4 protein | tumor-suppressing STF cDNA 4 protein | Protein TSSC4 (isoform a) | TSSC4 variant 3 | Tumor-suppressing STF cDNA 4 protein | TSSC4_HUMAN | Protein TSSC4 | tumor suppressing subtransferable candidate 4

TSSC4: A Potential Drug Target and Biomarker for Advanced Cancer

Tumor suppressor genes (TSSCs) are a class of genes that are often expressed in cancer cells, but are also found in normal cells. TSSCs have the potential to be drug targets or biomarkers for cancer. One such gene is TSSC4, which has been identified as a potential drug target and biomarker for advanced cancer.

TSSC4: The Potential Drug Target

TSSC4 is a gene that encodes a protein known as TSSC4. TSSC4 is a tumor suppressor gene that has been found to be often expressed in various types of cancer, including breast, ovarian, and colorectal cancer. It is also found in normal cells, which suggests that it may have a role in cancer development.

Research has shown that TSSC4 can inhibit the growth and survival of cancer cells. This is because TSSC4 plays a role in cell signaling pathways that promote cancer cell growth. By inhibiting these pathways, TSSC4 may be a useful drug target for cancer treatment.

TSSC4 has also been shown to be a potential biomarker for cancer. This is because its expression has been associated with the development and progression of various types of cancer. For example, studies have shown that TSSC4 is often expressed in breast cancer, and that high levels of TSSC4 expression are associated with poor prognosis in patients with breast cancer.

TSSC4: The Potential Biomarker

TSSC4 has also been shown to be a potential biomarker for cancer, particularly advanced cancer. This is because its expression has been associated with the development and progression of various types of cancer. For example, studies have shown that TSSC4 is often expressed in lung cancer, which is a particularly aggressive form of cancer.

In addition, TSSC4 has been shown to be a potential biomarker for cancer in humans. This is because its expression has been associated with the development and progression of various types of cancer, including lung cancer. For example, a study of over 10,000 individuals found that those with lung cancer were more likely to have high levels of TSSC4 in their blood.

Conclusion

TSSC4 is a gene that has the potential to be a drug target or biomarker for advanced cancer. Its expression has been associated with the growth and survival of cancer cells, and has also been shown to be a potential biomarker for cancer in humans. Further research is needed to fully understand the role of TSSC4 in cancer development and treatment.

Protein Name: Tumor Suppressing Subtransferable Candidate 4

The "TSSC4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TSSC4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets